MML Investors Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,333
Closed -$85.9K 3300
2026
Q1
$85.9K Buy
+14,333
New +$108K ﹤0.01% 2905
2023
Q2
Sell
-13,729
Closed -$323K 2333
2023
Q1
$323K Sell
13,729
-8,874
-39% -$238K ﹤0.01% 1634
2022
Q4
$631K Sell
22,603
-2,282
-9% -$58.3K ﹤0.01% 1388
2022
Q3
$582K Buy
24,885
+6,014
+32% +$182K ﹤0.01% 1347
2022
Q2
$637K Buy
18,871
+528
+3% +$18.5K ﹤0.01% 1287
2022
Q1
$641K Buy
18,343
+1,062
+6% +$36.3K ﹤0.01% 1326
2021
Q4
$526K Sell
17,281
-2,001
-10% -$65.2K ﹤0.01% 1380
2021
Q3
$632K Buy
19,282
+7,464
+63% +$239K 0.01% 1237
2021
Q2
$358K Buy
+11,818
New +$389K ﹤0.01% 1508

Other funds holding OGN

MML Investors Services's OGN Position: Q2 2026 in Review

MML Investors Services sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 14,333 shares — an estimated $85.9K sold.

MML Investors Services first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $641K in Q1 2022. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • MML Investors Services reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • MML Investors Services sold 14,333 Organon & Co shares in Q2 2026, an estimated $85.9K.
  • MML Investors Services first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • MML Investors Services's Organon & Co position peaked at $641K in Q1 2022.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.